Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02614755 · ClinicalTrials.gov registry record
An Observational Study of Lumosity in Seniors
A clinical trial, sponsored by Lumos Labs.
- Completed
- Registry status
- 68
- Enrollment target
NCT02614755: Completed study, sponsored by Lumos Labs.
NCT02614755 is a clinical trial that has completed, run by Lumos Labs. The registered enrollment target is 68 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02614755 has completed, sponsored by Lumos Labs.
- COMPLETED
- Registry status
- 68 participants
- Enrollment target
Study Summary
The primary objective of this observational study is to determine performance characteristics and usability of Lumosity and the Brain Performance Test in a group of older adult volunteers.
Primary Outcome
Using self-report surveys administered to participants at baseline, 3 months and 6 months, investigators will calculate a usability score of Lumosity.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2015-11 |
| Est. Completion | 2017-05-23 |
What the finished NCT02614755 record still lists
NCT02614755 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 68 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02614755 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02614755 about?
NCT02614755 is a clinical study titled "An Observational Study of Lumosity in Seniors". The primary objective of this observational study is to determine performance characteristics and usability of Lumosity and the Brain Performance Test in a group of older adult volunteers.
What is the current status of trial NCT02614755?
This trial is currently completed. The enrollment target is 68 participants. The study started on 2015-11. Estimated completion is 2017-05-23.
Who is sponsoring clinical trial NCT02614755?
This trial is sponsored by Lumos Labs, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia